Related Experiment Video

Updated: Aug 1, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

Defining criteria for anti-mannan antibodies to protect against candidiasis

J E Cutler1

  • 1The Research Institute for Children and LSUHSC, Dept of Pediatrics and Dept of Microbiology, Children's Hospital, New Orleans, LA 70118, USA. jcutler@chnola-research.org

Current Molecular Medicine
|June 28, 2005
PubMed

Insights

Developing a safe and effective vaccine against Candida species is crucial for preventing candidiasis. Antibodies targeting Candida mannan components show promise in protecting against fungal infections, particularly disseminated candidiasis.

Area of Science:

  • Immunology
  • Mycology
  • Vaccinology

Background:

  • Candidiasis, including disseminated and mucocutaneous forms like Candida vaginitis, poses a significant health challenge.
  • Current prevention strategies for candidiasis are limited, highlighting the need for novel immunological approaches.
  • Candida albicans, Candida tropicalis, and Candida glabrata are key etiological agents responsible for various candidiasis infections.

Purpose of the Study:

  • To explore the potential of immunological strategies for preventing hematogenously disseminated candidiasis and mucocutaneous disease.
  • To identify protective antigens and antibody targets for a potential long-acting and safe vaccine against common Candida species.
  • To elucidate the mechanisms underlying antibody-mediated protection against candidiasis, particularly disseminated and vaginal infections.

Main Methods:

  • Experimental animal models were used to investigate protective immune responses against Candida mannan components.
  • Antibody-mediated protection was assessed against various Candida species, including Candida albicans, Candida tropicalis, and Candida glabrata.
  • The role of complement factor C3 deposition in antibody-mediated resistance against disseminated candidiasis was experimentally evaluated.

Main Results:

  • Antibodies specific for short-chain beta-linked oligomannosides demonstrated protective efficacy against candidiasis in experimental models.
  • Rapid deposition of complement factor C3 onto the yeast cell wall by antibodies was identified as essential for resistance against disseminated candidiasis.
  • While protective mechanisms against vaginal candidiasis require further study, antibody-mediated complement deposition is key for disseminated infections.

Conclusions:

  • Antibodies targeting specific Candida mannan components, particularly short-chain beta-linked oligomannosides, offer a promising avenue for candidiasis prevention.
  • The development of a vaccine eliciting such antibodies could significantly reduce the incidence of candidiasis caused by major Candida species.
  • Complement factor C3 deposition is a critical mechanism for antibody-mediated protection against disseminated candidiasis, underscoring its importance in vaccine design.

More Related Videos

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis07:57

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis

Published on: December 8, 2011

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms06:50

A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms

Published on: September 16, 2022

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...